167 filings
Page 7 of 9
8-K
krwd4dg
29 Jul 14
Cempra, Inc. Reports Second Quarter 2014 Financial and Operating Results
12:00am
8-K
p5ib xb2zgm
2 Jul 14
Entry into a Material Definitive Agreement
12:00am
8-K
mqy2wh9xjw p8zlpja0
3 Jun 14
This presentation contains forward-looking statements regarding future events. These
12:00am
8-K
0pmrqgbwl9tsp7thl0u
29 May 14
Departure of Directors or Certain Officers
12:00am
8-K
ccwbpjf tkrio6k
22 May 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ii7t1wjma
8 May 14
Other Events
12:00am
8-K
6pd kc8tivyuxy6go1hi
6 May 14
Cempra Presents Late-Breaker on Solithromycin’s Anti NASH
12:00am
8-K
jd6ct37k2 hu7fr8b8hk
29 Apr 14
Cempra, Inc. Reports First Quarter 2014 Financial and Operating Results
12:00am
8-K
efh6y5th0 tw3oggs
2 Apr 14
Cempra to Present Late-Breaker on Solithromycin Reducing Inflammation in an Animal Model for Cancer Chemotherapy-Induced Lung Injury
12:00am
8-K
i05p5qc6
27 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
i5hzss1 ohgp7l
20 Feb 14
Other Events
12:00am
8-K
wo90fhvsxw 7slhwzz
11 Feb 14
Other Events
12:00am
8-K
prgdds
16 Dec 13
Other Events
12:00am
8-K
8a1upndmlkvnuzh qz
27 Nov 13
Departure of Directors or Certain Officers
12:00am
8-K
6yulox8p5 qfrdcig
30 Oct 13
Cempra, Inc. Receives U.S. Orphan Drug Designation for Taksta™ for Treatment of
12:00am
8-K
qko4h
29 Oct 13
Cempra, Inc. Reports Third Quarter 2013 Financial and Operating Results
12:00am
8-K
7jwz9uwyvw8 u8697
13 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
489zxmh
30 Jul 13
Cempra, Inc. Reports Second Quarter 2013 Financial and Operating Results
12:00am
8-K
083jm
9 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
cqakzwo7v2k932
19 Jun 13
Other Events
12:00am